Down-regulation of vascular PPAR-γ contributes to endothelial dysfunction in high-fat diet-induced obese mice exposed to chronic intermittent hypoxia

• Published in: Biochemical and biophysical research communications 2017-10, Vol.492 (2), p.243-248
• Main Authors: Zhang, Yanan, Zhang, Chunlian, Li, Haiou, Hou, Jingdong
• Format: Article
• Language: English
• Subjects: Animals; Chronic intermittent hypoxia; Diet, High-Fat - adverse effects; Down-Regulation; Endothelial dysfunction; Endothelium, Vascular - metabolism; Endothelium, Vascular - physiopathology; Hypoxia - complications; Hypoxia - metabolism; Hypoxia - physiopathology; Inflammation; Inflammation - complications; Inflammation - metabolism; Inflammation - physiopathology; Male; Mice, Inbred C57BL; Mice, Obese; Nitric Oxide Synthase Type III - metabolism; Obesity; Obesity - etiology; Obesity - metabolism; Obesity - physiopathology; Obstructive sleep apnea; Oxidative Stress; PPAR gamma - analysis; PPAR gamma - metabolism; Sleep Apnea, Obstructive
• ISSN: 0006-291X; 1090-2104
• DOI: 10.1016/j.bbrc.2017.08.058

Obstructive sleep apnea (OSA), characterized by chronic intermittent hypoxia (CIH), is associated with endothelial dysfunction. The prevalence of OSA is linked to an epidemic of obesity. CIH has recently been reported to cause endothelial dysfunction in diet-induced obese animals by exaggerating oxidative stress and inflammation, but the underlying mechanism remains unclear. PPAR-γ, a ligand-inducible transcription factor that exerts anti-oxidant and anti-inflammatory effects, is down-regulated in the peripheral tissues in diet-induce obesity. We tested the hypothesis that down-regulation of vascular PPAR-γ in diet-induced obesity enhances inflammation and oxidative stress in response to CIH, resulting in endothelial dysfunction. Male C57BL/6 mice were fed either a high-fat diet (HFD) or a low-fat diet (LFD) and simultaneously exposed to CIH or intermittent air for 6 weeks. An additional HFD group received a combination of CIH and PPAR-γ agonist pioglitazone for 6 weeks. Endothelial-dependent vasodilation was impaired only in HFD group exposed to CIH, compared with other groups, but was restored by concomitant pioglitazone treatment. Molecular studies revealed that vascular PPAR-γ expression and activity were reduced in HFD groups, compared with LFD groups, but were reversed by pioglitazone treatment. In addition, CIH elevated vascular expression of NADPH oxidase 4 and dihydroethidium fluorescence, and increased expression of proinflammatory cytokines TNF-α and IL-1β in both LFD and HFD groups, but these increases was significantly greater in HFD group, along with decreased vascular eNOS activity. Pioglitazone treatment of HFD group prevented CIH-induced changes in above molecular markers. The results suggest that HFD-induced obesity down-regulates vascular PPAR-γ, which results in exaggerated oxidative stress and inflammation in response to CIH, contributing to endothelial dysfunction. This finding may provide new insights into the mechanisms by which OSA induces endothelial dysfunction and other cardiovascular disease in patients with obesity. •High-fat diet-induced obesity reduces vascular PPAR-γ activity.•Reduced PPAR-γ exaggerates oxidative stress and inflammation in response to hypoxia.•Reduced PPAR-γ causes endothelial dysfunction in obesity in response to hypoxia.